Literature DB >> 11162832

Hepatitis C virus structural proteins reside in the endoplasmic reticulum as well as in the intermediate compartment/cis-Golgi complex region of stably transfected cells.

G Martire1, A Viola, L Iodice, L V Lotti, R Gradini, S Bonatti.   

Abstract

The intracellular localization of hepatitis C virus structural proteins was analyzed by confocal immunofluorescence microscopy, cell fractionation, and immunoelectron microscopy in stably transfected cells that do not overexpress the viral proteins. The results strongly suggest that at steady state the structural proteins reside not only in the endoplasmic reticulum but also in the intermediate compartment and cis-Golgi complex region. By analogy with other viral systems, this finding raises the possibility that the intermediate compartment and cis-Golgi complex play a role in the assembly and budding of hepatitis C virus. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162832     DOI: 10.1006/viro.2000.0733

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  KDEL and KKXX retrieval signals appended to the same reporter protein determine different trafficking between endoplasmic reticulum, intermediate compartment, and Golgi complex.

Authors:  Mariano Stornaiuolo; Lavinia V Lotti; Nica Borgese; Maria-Rosaria Torrisi; Giovanna Mottola; Gianluca Martire; Stefano Bonatti
Journal:  Mol Biol Cell       Date:  2003-03       Impact factor: 4.138

2.  Membrane binding properties and terminal residues of the mature hepatitis C virus capsid protein in insect cells.

Authors:  Tomoaki Ogino; Hiroyuki Fukuda; Shinobu Imajoh-Ohmi; Michinori Kohara; Akio Nomoto
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

3.  Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector.

Authors:  Heather J Ezelle; Dubravka Markovic; Glen N Barber
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Persistent and transient replication of full-length hepatitis C virus genomes in cell culture.

Authors:  Thomas Pietschmann; Volker Lohmann; Artur Kaul; Nicole Krieger; Gabriele Rinck; Gabriel Rutter; Dennis Strand; Ralf Bartenschlager
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Full-length core sequence dependent complex-type glycosylation of hepatitis C virus E2 glycoprotein.

Authors:  Li-Xin Zhu; Jing Liu; Ying-Chun Li; Yu-Ying Kong; Caroline Staib; Gerd Sutter; Yuan Wang; Guang-Di Li
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

6.  Characterization of hepatitis C virus core protein multimerization and membrane envelopment: revelation of a cascade of core-membrane interactions.

Authors:  Li-Shuang Ai; Yu-Wen Lee; Steve S-L Chen
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

7.  Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus.

Authors:  Koichi Watashi; Makoto Hijikata; Ayako Tagawa; Takahiro Doi; Hiroyuki Marusawa; Kunitada Shimotohno
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

Review 8.  Access of viral proteins to mitochondria via mitochondria-associated membranes.

Authors:  Chad D Williamson; Anamaris M Colberg-Poley
Journal:  Rev Med Virol       Date:  2009-05       Impact factor: 6.989

Review 9.  Post-translational modifications of hepatitis C viral proteins and their biological significance.

Authors:  Jana Hundt; Zhubing Li; Qiang Liu
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

10.  Expression of unmodified hepatitis C virus envelope glycoprotein-coding sequences leads to cryptic intron excision and cell surface expression of E1/E2 heterodimers comprising full-length and partially deleted E1.

Authors:  Julie Dumonceaux; Emmanuel G Cormier; Francis Kajumo; Gerald P Donovan; Jayanta Roy-Chowdhury; Ira J Fox; Jason P Gardner; Tatjana Dragic
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.